Your browser doesn't support javascript.
loading
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).
Chincarini, A; Peira, E; Morbelli, S; Pardini, M; Bauckneht, M; Arbizu, J; Castelo-Branco, M; Büsing, K A; de Mendonça, A; Didic, M; Dottorini, M; Engelborghs, S; Ferrarese, C; Frisoni, G B; Garibotto, V; Guedj, E; Hausner, L; Hugon, J; Verhaeghe, J; Mecocci, P; Musarra, M; Queneau, M; Riverol, M; Santana, I; Guerra, U P; Nobili, F.
Afiliación
  • Chincarini A; Istituto Nazionale di Fisica Nucleare (INFN), Genova, via Dodecaneso 33, I-16146, Italy. Electronic address: andrea.chincarini@ge.infn.it.
  • Peira E; Istituto Nazionale di Fisica Nucleare (INFN), Genova, via Dodecaneso 33, I-16146, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Morbelli S; Nuclear Medicine Unit (DISSAL), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Pardini M; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Bauckneht M; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Arbizu J; Department of Nuclear Medicine, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain.
  • Castelo-Branco M; Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), ICNAS, Faculty of Medicine, University of Coimbra, Portugal.
  • Büsing KA; Institut für Klinische Radiologie und Nuklearmedizin der Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany.
  • de Mendonça A; Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
  • Didic M; Service de Neurologie et Neuropsychologie, Pôle de Neurosciences Cliniques, Centre Hospitalo-Universitaire de la Timone, AP-HM, Marseille, France.
  • Dottorini M; Medicina Nucleare, Azienda Ospedaliera di Perugia, Italy.
  • Engelborghs S; Reference Center of Biological Markers for Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Belgium; Department of Neurology and Center for Neurosciences, Universitair Ziekenhuis Brussel and Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Ferrarese C; Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, San Gerardo Hospital, 20900, (MI), Monza, Italy.
  • Frisoni GB; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland; Memory Clinic, University Hospital of Geneva, Geneva, Switzerland.
  • Garibotto V; Nuclear Medicine and Molecular Imaging Division, Department of Medical Imaging, University Hospitals of Geneva, Genève 14, Switzerland.
  • Guedj E; Service de Médecine Nucléaire, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France; Aix-Marseille Université, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France.
  • Hausner L; Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Hugon J; Center of Cognitive Neurology, Lariboisiere FW Hospital AP-HP, University of Paris Diderot, 75010 Paris, France.
  • Verhaeghe J; Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium.
  • Mecocci P; Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
  • Musarra M; Nuclear Medicine Service, University of Milano Bicocca, Milan, Italy.
  • Queneau M; Molecular and Functional Imaging Center, Centre Cardiologique du Nord, Saint-Denis, Paris, France.
  • Riverol M; Department of Neurology, Clínica Universidad de Navarra, Spain.
  • Santana I; Department of Neurology, Dementia Clinic, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Guerra UP; Nuclear Medicine, Fondazione Poliambulanza, Istituto Ospedaliero, Brescia, Italy.
  • Nobili F; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Neuroimage Clin ; 23: 101846, 2019.
Article en En | MEDLINE | ID: mdl-31077984
BACKGROUND: amyloid-PET reading has been classically implemented as a binary assessment, although the clinical experience has shown that the number of borderline cases is non negligible not only in epidemiological studies of asymptomatic subjects but also in naturalistic groups of symptomatic patients attending memory clinics. In this work we develop a model to compare and integrate visual reading with two independent semi-quantification methods in order to obtain a tracer-independent multi-parametric evaluation. METHODS: We retrospectively enrolled three cohorts of cognitively impaired patients submitted to 18F-florbetaben (53 subjects), 18F-flutemetamol (62 subjects), 18F-florbetapir (60 subjects) PET/CT respectively, in 6 European centres belonging to the EADC. The 175 scans were visually classified as positive/negative following approved criteria and further classified with a 5-step grading as negative, mild negative, borderline, mild positive, positive by 5 independent readers, blind to clinical data. Scan quality was also visually assessed and recorded. Semi-quantification was based on two quantifiers: the standardized uptake value (SUVr) and the ELBA method. We used a sigmoid model to relate the grading with the quantifiers. We measured the readers accord and inconsistencies in the visual assessment as well as the relationship between discrepancies on the grading and semi-quantifications. CONCLUSION: It is possible to construct a map between different tracers and different quantification methods without resorting to ad-hoc acquired cases. We used a 5-level visual scale which, together with a mathematical model, delivered cut-offs and transition regions on tracers that are (largely) independent from the population. All fluorinated tracers appeared to have the same contrast and discrimination ability with respect to the negative-to-positive grading. We validated the integration of both visual reading and different quantifiers in a more robust framework thus bridging the gap between a binary and a user-independent continuous scale.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Placa Amiloide / Tomografía de Emisión de Positrones / Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neuroimage Clin Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Placa Amiloide / Tomografía de Emisión de Positrones / Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neuroimage Clin Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos